Complications-Centric Management of Type 2 Diabetes: A Cardiometabolic Approach: Part 1
In the first part, Prof. Issacs discussed the shift from a glucose-centric to a complications-centric approach, highlighting the importance of comprehensive cardiometabolic risk reduction. He provided an overview of type 2 diabetes and emphasized the need for clinical management through screening, diagnosis, and comprehensive risk assessment. Glycemic management, cardiovascular risk management, and weight management were identified as key components of this process. Treatment options were explored, including lifestyle modifications, pharmacological interventions, and surgical options. Prof. Issacs also stressed the importance of a multidisciplinary care approach, alongside patient education and adherence, to improve outcomes. Finally, he addressed the role of community and public health interventions in managing diabetes effectively.
Complications-Centric Management of Type 2 Diabetes: A Cardiometabolic Approach: Part 2
In the second segment, Prof. Richard Donnelly offers an in-depth analysis of diabetes treatment and management in the Asia-Pacific region. He begins by examining current trends in the epidemiology of type 2 diabetes in Southeast Asia, highlighting the unique presentations of T2D in these populations. Prof. Donnelly then delves into the pathophysiology of diabetes within this region. He further explores the concept of type 2 diabetes as a comprehensive syndrome of cardiometabolic risk, emphasizing the importance of considering associated complications and comorbidities that affect cardiovascular, hepatic, and renal health. Additionally, he addresses strategies for managing excess body weight in individuals with obesity and discusses recent advancements in pharmacological development.